Top compounds associated with response to NTRK3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.071 0.04
mRNA OSU-03012 GDSC1000 pan-cancer AAC -0.069 0.05
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.069 0.05
mRNA shikonin GDSC1000 pan-cancer AAC -0.069 0.05
mRNA ZM-447439 GDSC1000 pan-cancer AAC -0.07 0.05
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC 0.069 0.06
mRNA IOX2 GDSC1000 pan-cancer AAC -0.064 0.06
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.066 0.06
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.059 0.06
Download CSV